HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Microaxial Left Ventricular Assist Device Versus Intraaortic Balloon Pump as a Bridge to Transplant.

AbstractBACKGROUND:
Heart transplantation (HTx) candidates supported by Impella (Abiomed, Danvers, MA) or intraaortic balloon pump (IABP), who demonstrate evidence of cardiogenic shock, may qualify for waitlist status 2 without exception under the new donor heart allocation system. However limited data comparing Impella versus IABP as a bridge to HTx exist.
METHODS:
The United Network for Organ Sharing database was queried for adults listed and/or transplanted between January 2014 and February 2020. Temporal trends regarding Impella and IABP use were analyzed using the Royston trend test and χ2 test. Waitlist mortality was examined using Fine-Gray competing risks analysis. Post-HTx 180-day survival was analyzed using the Kaplan-Meier method and Cox proportional hazards models.
RESULTS:
Impella use increased from 0.2% in 2014 to 2.6% in 2020 (P < .01) and from 0.4% to 2.2% (P < .01) under the new allocation system. IABP use increased from 4.9% in 2014 to 27.6% in 2020 (P < .01) and from 6.7% to 26.6% (P < .01) under the new allocation system. Post-HTx survival was similar between groups (adjusted hazard ratio, 0.82; 95% CI, 0.38-1.78) despite more preoperative ventilation (3.6% vs 1.1%, P = .01) and higher model for end-stage liver disease excluding international normalized ratio scores (12.4 vs 9.5, P < .01) among Impella-supported recipients. Under the new system Impella-supported candidates were at higher risk of waitlist delisting compared with IABP-supported candidates (subhazard ratio, 2.42; 95% CI, 1.19-4.92).
CONCLUSIONS:
Post-HTx survival is comparable between Impella-supported and IABP-supported recipients despite worse preoperative profiles among Impella-supported recipients. Higher risk of waitlist delisting among Impella-supported candidates under the new allocation system requires close attention.
AuthorsTaylor Nordan, Andre C Critsinelis, Shant H Mahrokhian, Navin K Kapur, Amanda Vest, David DeNofrio, Frederick Y Chen, Gregory S Couper, Masashi Kawabori
JournalThe Annals of thoracic surgery (Ann Thorac Surg) Vol. 114 Issue 1 Pg. 160-166 (07 2022) ISSN: 1552-6259 [Electronic] Netherlands
PMID34419433 (Publication Type: Journal Article)
CopyrightCopyright © 2022 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Topics
  • Adult
  • End Stage Liver Disease
  • Heart Transplantation
  • Heart-Assist Devices
  • Humans
  • Intra-Aortic Balloon Pumping
  • Retrospective Studies
  • Severity of Illness Index
  • Shock, Cardiogenic
  • Tissue Donors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: